Drug Survival on First Biologic Therapy Among Late-Onset Rheumatoid Arthritis Patients Compared to Early-Onset Patients: A Population-Based Cohort Study.
Helana JeriesRula DaoodBasem HijaziAvivit Golan-CohenIlan GreenEugene MerzonMohammad E NaffaaFadi HassanPublished in: Musculoskeletal care (2024)
Late-onset RA patients were treated with biologics to a lesser extent than early-onset patients, but no differences were observed in drug survival times at the first bDMARD between the two groups.
Keyphrases
- early onset
- late onset
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- rheumatoid arthritis
- prognostic factors
- rheumatoid arthritis patients
- peritoneal dialysis
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- idiopathic pulmonary fibrosis
- drug induced
- interstitial lung disease